Masimo Corporation (MASI)
Masimo (MASI) Q3 Earnings and Revenues Top Estimates
Masimo (MASI) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.63 per share a year ago.
Masimo (MASI) Reports Next Week: Wall Street Expects Earnings Growth
Masimo (MASI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Masimo smartwatches infringe Apple design patents, US jury says
Apple convinced a federal jury on Friday that health monitoring tech company Masimo's smartwatches infringe two of its design patents.
Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report?
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Masimo (MASI) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
As of Oct. 10, 2024, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Here's Why You Should Add Masimo Stock to Your Portfolio Now
MASI's R&D activities raise optimism about the stock.
Why Masimo Stock Crushed the Market Today
The medical technology specialist, known for its monitoring devices, named an interim CEO. This followed the resignation of its existing chief.
Masimo's Joe Kiani resigns as CEO after board ouster
Masimo said on Wednesday that Joe Kiani has decided to resign as CEO, days after shareholders voted to remove him from the company's board.
Masimo (MASI) Surges 8.7%: Is This an Indication of Further Gains?
Masimo (MASI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Masimo CEO Joe Kiani ousted from board after proxy fight; Politan wins two seats
Activist investor Politan won the two board seats it was seeking at Masimo, defeating founder Joe Kiani and another director at the shareholder vote. Politan nominees Darlene Solomon and Bill Jellison will join two others who were added to the board in a prior proxy fight.
Masimo shareholders elect both Politan nominees in bitter boardroom battle
Masimo Corp shareholders elected both director candidates proposed by veteran activist investor Quentin Koffey's hedge fund Politan Capital Management, in one of the most contentious boardroom battles of the year.
